Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 2;8(4):102006.
doi: 10.1016/j.matt.2025.102006. Epub 2025 Feb 25.

Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responses

Affiliations

Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responses

Julie Baillet et al. Matter. .

Abstract

The threat of future coronavirus pandemics requires developing effective vaccine technologies that provide broad and long-lasting protection against circulating and emerging strains. Here we report a multivalent liposomal hydrogel vaccine technology comprising the receptor binding domain (RBD) of up to four SARS and MERS coronavirus strains non-covalently displayed on the surface of the liposomes within the hydrogel structure. The multivalent presentation and sustained exposure of RBD antigens improved the potency, neutralizing activity, durability, and consistency of antibody responses across homologous and heterologous coronavirus strains in a naïve murine model. When administrated in animals pre-exposed to wild-type SARS-CoV-2 antigens, liposomal hydrogels elicited durable antibody responses against the homologous SARS and MERS strains for over six months and elicited neutralizing activity against the immune-evasive SARS-CoV-2 variant Omicron BA.4/BA.5. Overall, the tunable liposomal hydrogel platform we report here generates robust responses against diverse coronaviruses, supporting global efforts to respond to future viral outbreaks.

Keywords: Coronavirus; Drug Delivery; Hydrogels; Liposomes; Vaccines.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest E.A.A. and J.H.K. are listed as inventors on a patent application describing the technology reported in this manuscript. E.A.A. is a co-founder, equity holder, and advisor of Appel Sauce Studios, which holds an exclusive license to the technology reported in this manuscript. All other authors have no interests to declare.

Similar articles

References

    1. Pardi N, and Krammer F (2024). mRNA vaccines for infectious diseases — advances, challenges and opportunities. Nature Reviews Drug Discovery 23, 838. - PubMed
    1. Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, De Silva TI, Peacock SJ, Barclay WS, De Silva TI, Towers GJ, et al. (2023). SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nature Reviews Microbiology 21, 162. - PMC - PubMed
    1. Moyle PM, and Toth I (2013). Modern Subunit Vaccines: Development, Components, and Research Opportunities. ChemMedChem 8, 360. - PubMed
    1. Irvine DJ, Aung A, and Silva M (2020). Controlling timing and location in vaccines. Advanced Drug Delivery Reviews 158, 91. - PMC - PubMed
    1. Ou BS, Saouaf OM, Baillet J, and Appel EA (2022). Sustained delivery approaches to improving adaptive immune responses. Advanced Drug Delivery Reviews 187, 114401. - PubMed

LinkOut - more resources